Articles

Utility of clinical comprehensive genomic characterisation for diagnostic categorisation in patients presenting with hypocellular bone marrow failure syndromes

Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia;
Royal Children's Hospital, Melbourne, Australia;
Royal Children's Hospital, Melbourne, Australia;
Royal Children's Hospital, Melbourne, Australia;
Transfusion Research Unit, Monash University, Melbourne, Australia;
Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne, Australia;
Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne, Australia;
Children Health Queensland and University of Queensland, South Brisbane QLD, Australia;
Children Health Queensland and University of Queensland, South Brisbane QLD, Australia;
Department of Haematology, Austin Health, Melbourne, Australia;
Melbourne Genomics Health Alliance, Parkville VIC, Australia
Melbourne Genomics Health Alliance, Parkville VIC, Australia
Melbourne Genomics Health Alliance, Parkville VIC, Australia
Clinical Haematology, Peter MacCallum Cancer Centre/Royal Melbourne Hospital, Melbourne, Australia;
Haematologica Early view Feb 13, 2020 https://doi.org/10.3324/haematol.2019.237693